NICE guidance could boost NRT sales
This article was originally published in Scrip
NICE, England and Wales' health technology assessment institute, has released new guidance which recommends using nicotine replacement therapies (NRTs) to help people who want to reduce the amount they smoke but cannot quit in one go.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.